about
Drug interactions with grapefruit juice: an updateZolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlationsExtrapolating in vitro data on drug metabolism to in vivo pharmacokinetics: evaluation of the pharmacokinetic interaction between amitriptyline and fluoxetine.Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors.Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.From disordered eating to addiction: the "food drug" in bulimia nervosa.Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.In vitro approaches to predicting drug interactions in vivo.Water safety, medication disposal, and more: an update.Water, water everywhere: but is it safe to drink? Return to a muddy topic.Influenza vaccines-thoughts and current status.Selective serotonin reuptake inhibitor antidepressants: cardiovascular complications--sorting through findings.In vitro biotransformation of sildenafil (Viagra) in the male rat: the role of CYP2C11.The liver: a vulnerable helper.The effect of age on sildenafil biotransformation in rat and mouse liver microsomes.Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.Too good to be true? Aspirin and schizophrenia.Factors influencing variability in clinical trials and in individuals' responses to treatment.Alprazolam is another substrate for human cytochrome P450-3A isoforms.Newer antidepressants: further reflections.On top of atopy.Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans.Absolute bioavailability of imipramine: influence of food.Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate.Atropine overdose in three children.Conflicts of interest, redundant publication, and identification of authorship: a plea for trust instead of suspicion.Lorazepam attenuates the behavioral effects of dizocilpine.More on potassium, the heart, and antipsychotic agents.Antagonists, inverse agonists, and protagonists.Absorption of oral and intramuscular chlordiazepoxideFactors influencing blood concentrations of chlordiazepoxide: a use of multiple regression analysisChronic morphine administration augments benzodiazepine binding and GABAA receptor functionThe behavioral effects of nicotinamide adenine dinucleotide in chronic schizophreniaSexual dysfunction associated with mesoridazine besylate (serentil)Chlordiazepoxide, expectation and hostilityAbsorption and disposition of ibuprofen in the elderlyThe clinician and drug interactions--an update
P50
Q28209309-55EC6C26-C3CB-4076-90D0-ED868969442CQ28343408-0882B671-A42D-478C-8242-B7D636CF4ED0Q30577448-55D1CA41-328C-4B95-B35C-46EA4C7773D5Q33148910-F2F26171-6091-436E-99B7-9EE6C52C180DQ33744292-90C1EBBF-205A-4180-A6C9-528BE064363EQ34507935-60CD34FA-0FD6-4554-89F8-0880420E8912Q35825681-C0EDF092-1282-4309-9341-32821FE8035AQ38006396-577ADA17-938C-40BA-B9A3-B1CFBD34ED76Q40927752-E9CBBF99-5E52-4C18-A29F-E9694396F6CBQ41692688-38835BC4-FE24-4B6B-A1B2-F6FBD89ED4CEQ43313273-6261EDCA-E009-45C9-B3DB-E0656186E1C6Q43360647-08D3A3B9-63E8-4946-9DC4-EE79F31F4BB1Q43568041-14EB31E3-0AA9-491A-A295-D202A995A352Q43761126-95CDD094-0D1F-48F7-ABF3-643C9D7394B1Q43999022-D13DF395-6E27-450F-9732-968EC1652F8BQ44180404-502D51EF-8979-42E6-A4E8-C483458AD625Q44626639-7F221F42-E029-4D95-B801-CE4AE11ECEEFQ44897899-850BC360-DA17-488A-A674-95D86F756110Q46130343-8E4E8E77-4856-4AB7-9BF1-516D6401309AQ46908551-36E97E68-2D89-4411-89D4-445B21880C45Q48001182-3C7B7863-4B4A-4A46-B825-44A35FF3B42FQ48731639-E1FECAC7-DF23-44C4-B61C-66486A0C2022Q50979295-96200C56-8F06-46AB-B8CE-24876146AE36Q51088676-3691754E-7DC8-4CC2-9F44-26A9D050FBDBQ51565597-5B3C4B86-B1CD-44AF-BFEF-FA974448A1B5Q51644319-79295324-A93A-4BC1-B5EE-96CA14ECF8C6Q51871267-F605E19B-78BD-45D1-A463-46A433772A0AQ52733782-90B2ECB5-A8A0-4572-9B66-70642FDFFCFEQ53575863-88D34831-AB73-46B3-9C12-7CAE307E7CA8Q53937435-4949BF60-29AA-4989-AC2F-4CD0C5918392Q54353929-B4266BC1-BCFE-48D9-AEF0-C395E4B2DBC8Q55036753-78E03759-CB00-4F4B-9506-E8C6603D7496Q59488394-41D54C38-910C-4C13-BC4F-74F4A409222EQ66902868-9AC953A6-73C2-4AAF-9262-27A417547BE4Q67668041-7561A911-0889-4DB1-B066-4C1806105796Q68601710-B0B94DDB-E348-46F3-A8AB-BAD4E1095D61Q69454792-D7508501-97AE-485F-B0C7-84BA88028B33Q69891087-20A3AAC7-FF6C-4E0E-B2FE-57849CD25482Q70612534-296CAA6F-EF06-4FEC-95E3-8548656FCCA1Q71478796-D5CFA039-808D-4105-9298-5BB7A077ED60
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard I. Shader
@ast
Richard I. Shader
@en
Richard I. Shader
@es
Richard I. Shader
@nl
Richard I. Shader
@sl
type
label
Richard I. Shader
@ast
Richard I. Shader
@en
Richard I. Shader
@es
Richard I. Shader
@nl
Richard I. Shader
@sl
prefLabel
Richard I. Shader
@ast
Richard I. Shader
@en
Richard I. Shader
@es
Richard I. Shader
@nl
Richard I. Shader
@sl
P106
P1153
35601296700
P21
P31
P496
0000-0002-1888-7565